用于运输温度敏感疫苗的干冰颗粒可以使用吗？

对温度敏感药品的全球分销，特别是mRNA疫苗和生物样本，严格要求保持-70°C至-80°C之间的连续冷链。标准的凝胶包或机械制冷根本无法达到这些极端的低温条件。由我们的SL系列机器生产的干冰颗粒不仅适用，而且是完成这一关键任务的行业绝对标准。

Hospitals, pharmaceutical distribution hubs, and medical research facilities often rely on external gas suppliers for their dry ice. However, in the medical field, a delayed delivery or receiving degraded, sublimated dry ice can result in millions of dollars of ruined vaccines. By installing an on-site 干冰颗粒剂 like the SL-50 或者 SL-100, medical logistics centers eliminate supply chain vulnerabilities. You can instantly produce fresh, pure dry ice at a stable -78.5°C exactly when the insulated shipping containers are being prepared for dispatch.

Furthermore, the physical properties of the pellets play a vital role. Using our interchangeable dies, operators can produce 10mm or 16mm pellets. These spherical, high-density (1550 kg/m³) pellets can be effortlessly poured into the EPS (Expanded Polystyrene) dry ice shipping containers, tightly filling all the microscopic voids around the fragile vaccine vials. This creates an impenetrable, long-lasting thermal barrier that protects the life-saving medical cargo for days during cross-border transit, ensuring total compliance with stringent WHO (World Health Organization) cold chain guidelines.